Articles by Dawn M. Boothe, DVM, PhD, DACVIM, DACVCP - Veterinary Medicine
  • SEARCH:
Medicine Center
DVM Veterinary Medicine Featuring Information from:

ADVERTISEMENT

Articles by Dawn M. Boothe, DVM, PhD, DACVIM, DACVCP

What's new in small-animal drug therapy (Proceedings)

Aug 1, 2008

A test is available to detect the MDR-1 genetic deletion that leads to P-glycoprotein deficiencies in collies and related breeds.

Antimicrobial resistance in small animals: Is there a problem? (Proceedings)

Aug 1, 2008

Increasingly, the veterinary practitioner will find that the favorite drug of choice is no longer a viable option.

Reducing the risk of antimicrobial resistance: Picking the right drug (Proceedings)

Apr 1, 2008

Even experienced practitioners may not realize that giving a patient antibiotics affects not just that patient, but also their environment, and all the other people that come into contact with that environment.

Non-glucocorticoid immunomodulation in small animals (Proceedings)

Apr 1, 2008

Despite their marked efficacy in suppressing the immune system, alternatives to glucocorticoids must often be considered when treatment immune-mediated or chronic allergic diseases in dogs and cats.

Constant rate infusion versus IV bolus (Proceedings)

The must-knows
Apr 1, 2008

Dosing regimens are comprised of a route, dose and interval and are designed to achieve a plasma drug concentration (PDC) within a targeted therapeutic range.

Reducing the risk of antimicrobial resistance: Building the right dosing regimen (Proceedings)

Apr 1, 2008

Dosing regimens for antimicrobials should be related to MIC. However, simply achieving the MIC in the patient is not likely to be sufficient for a variety of reasons.

Antimicrobial therapy (Proceedings)

Is resistance a problem?
Apr 1, 2008

Increasingly, the veterinary practitioner will find that the favorite drug of choice is no longer a viable option.

Clinical case discussions (Proceedings)

From the lab to the labrador
Apr 1, 2008

The goal of antimicrobial therapy is to both eliminate bacteruria, but also, to avoid resistance.

Glucocorticoids (Proceedings)

Revisiting an old friend
Apr 1, 2008

For good reasons, glucocorticoids (GLs) have been the cornerstone of immunosuppressive therapy in humans and animals.

ADVERTISEMENT

Click here